SCHEMBL4463483

SCHEMBL4463483

CNC(=O)c1cc(Oc2cccc(-c3c[nH]c(C(=O)Nc4cc(C(F)(F)F)ccc4OC)c3)c2)ccn1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 12/20 0.64
KDR P35968 2/20 0.51
RET P07949 2/20 0.51
PLK4 O00444 1/20 0.51
AURKA O14965 1/20 0.51
MAPK13 O15264 1/20 0.51
JAK2 O60674 1/20 0.51
MAP4K4 O95819 1/20 0.51
ABL1 P00519 1/20 0.51
LCK P06239 1/20 0.51
FYN P06241 1/20 0.51
LYN P07948 1/20 0.51
ROS1 P08922 1/20 0.51
SRC P12931 1/20 0.51
RPS6KB1 P23443 1/20 0.51
EPHA2 P29317 1/20 0.51
TYK2 P29597 1/20 0.51
AXL P30530 1/20 0.51
FRK P42685 1/20 0.51
SYK P43405 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4469831 0.92 RAF1 (0.71) RAF1KDRRETPLK4AURKA
SCHEMBL4463604 0.89 RAF1 (0.51) RAF1KDRRETPLK4AURKA
SCHEMBL4473374 0.89 DDR2 (0.54) RAF1KDRRETDDR2BRAF
SCHEMBL9104786 0.88 RAF1 (0.49) RAF1KDRRETPLK4AURKA
SCHEMBL4470285 0.88 KDR (0.50) RAF1KDRRETPLK4AURKA
SCHEMBL4470556 0.88 RAF1 (0.49) RAF1KDRRETPLK4AURKA
SCHEMBL9106204 0.87 KDR (0.65) RAF1KDRRETPLK4AURKA
SCHEMBL4463609 0.86 RAF1 (0.51) RAF1KDRRETPLK4AURKA
SCHEMBL4476005 0.85 RAF1 (0.45) RAF1KDRRETDDR2MAPT
SCHEMBL5419926 0.85 RAF1 (0.72) RAF1KDRRETPLK4AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1685125-B1 Pyrrole derivatives useful for the treatment of proliferative diseases MERCK PATENT GMBH (DE) 2012-06-06 EP claimed
US-7598274-B2 N-methyl-4-{4-[5-(4-chloro-3-trifluoromethylphenylcarbamoyl)-1H-pyrrol-3-yl]-phenoxy}pyridine-2-carboxamide; Raf kinases inhibitors MERCK PATENT GMBH (DE) 2009-10-06 US claimed